{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-010548","form_type":"8-K","ticker":"PASG","cik":"0001787297","company_name":"Passage BIO, Inc.","filed_at":"2022-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.032923+00:00","generated_at":"2026-06-24T21:01:22.291096+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Passage Bio appoints Dr. Michael Kamarck as Class I director","bullets":["Dr. Kamarck appointed to board and Governance Committee, effective July 2, 2022.","He is Chairman of Sanofi Biotech Advisory Council and former CTO at Vir Biotechnology.","Received options to purchase 48,000 shares vesting over 36 months; cash per director policy.","Background includes ~30 years leadership at Merck, Wyeth, and Bayer."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-010548","json":"https://secwatch.observer/filing/0001558370-22-010548.json","markdown":"https://secwatch.observer/filing/0001558370-22-010548.md","text":"https://secwatch.observer/filing/0001558370-22-010548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787297/000155837022010548/0001558370-22-010548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787297/000155837022010548/pasg-20220702x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:01:22.291096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"97a4e9b20b","claim":"Dr. Michael Kamarck was appointed as Class I director at Passage BIO, Inc..","evidence_excerpt":"appointed Dr. Michael Kamarck as a Class I director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787297/000155837022010548/0001558370-22-010548-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}